Compare AVTX & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTX | YQ |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.9M | 22.7M |
| IPO Year | 2015 | 2020 |
| Metric | AVTX | YQ |
|---|---|---|
| Price | $17.53 | $1.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $36.80 | N/A |
| AVG Volume (30 Days) | ★ 793.8K | 3.6K |
| Earning Date | 05-11-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $3.39 | $1.26 |
| 52 Week High | $20.72 | $6.45 |
| Indicator | AVTX | YQ |
|---|---|---|
| Relative Strength Index (RSI) | 64.56 | 19.57 |
| Support Level | $17.18 | $1.70 |
| Resistance Level | $19.26 | $2.06 |
| Average True Range (ATR) | 1.19 | 0.14 |
| MACD | 0.27 | -0.06 |
| Stochastic Oscillator | 99.67 | 0.00 |
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
17 Education & Technology Group Inc is an education technology company in China. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.